DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Polycab India Limited — Press Release

NSE 1 hr ago·13 Oct 2026, 11:17 am

Polycab India

Polycab India Limited has informed stock exchanges about an order from the National Company Law Appellate Tribunal (NCLAT). The company released a press statement on October 13, 2026, addressing this specific legal development. This update is significant because it signals that the company is actively responding to a regulatory matter that could impact its operations or legal standing.

For investors, this news is important as it highlights a developing legal situation that requires monitoring. While the company has not disclosed the full details of the order, such notifications often precede material announcements regarding compliance or business continuity. Investors should watch for the company's future disclosures to understand the scope and potential implications of this NCLAT order on its business performance.